The US Bankruptcy Court granted an order for the joint administration of the Chapter 11 bankruptcy cases of Eiger BioPharmaceuticals, Inc., and its affiliates on April 5, 2024. The affiliates include Ebpi Merger, Inc., Eiger Biopharmaceuticals Europe Limited, Eigerbio Europe Limited, and Eb Pharma, LLC. The cases would be jointly administered for administrative and procedural purposes.

Eiger BioPharmaceuticals, Inc., has been designated as the lead debtor.